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The mechanobullous disease Hallopeau–Siemens recessive dystrophic epidermolysis bullosa (HS-RDEB) results
from mutations in the type VII collagen gene (COL7A1) on chromosome 3p21.31. Typically, there are frameshift,
splice site, or nonsense mutations on both alleles. In this report, we describe a patient with HS-RDEB, who was
homozygous for a new frameshift mutation, 345insG, in exon 3 of COL7A1. However, sequencing of parental
DNA showed that although the patient’s mother was a heterozygous carrier of this mutation, the father’s DNA
contained only wild-type sequence. Microsatellite marker analysis confirmed paternity and genotyping of 28
microsatellites spanning chromosome 3 revealed that the affected child was homozygous for every marker
tested with all alleles originating from a single maternal chromosome 3. Thus, the HS-RDEB phenotype in this
patient is due to complete maternal isodisomy of chromosome 3 and reduction to homozygosity of the mutant
COL7A1 gene locus. To our knowledge, there are no published reports of uniparental disomy (UPD) in
HS-RDEB; moreover, this case represents only the third example of UPD of chromosome 3 to be reported.
The severity of the HS-RDEB in this case was similar to other affected individuals and no additional phenotypic
abnormalities were observed, suggesting an absence of maternally imprinted genes on chromosome 3.
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INTRODUCTION
Recessive dystrophic epidermolysis bullosa (RDEB) is a
mechanobullous disorder associated with defective anchor-
ing fibrils at the dermal–epidermal junction and abnormalities
in type VII collagen gene and protein expression (Christiano
et al., 1997a; Fine et al., 2000). The molecular pathology of
RDEB involves loss-of-function mutations in the COL7A1
gene on chromosome 3p21.31 (Christiano et al., 1994).
Typically, the severe Hallopeau–Siemens (HS) subtype of
RDEB (OMIM 226600) results from nonsense, frameshift,
splice site or, less commonly, missense mutations on both
COL7A1 alleles (Jarvikallio et al., 1997; Whittock et al.,
1999; Uitto and Richard, 2004). Clinically, HS-RDEB is
associated with widespread mucocutaneous blisters and
erosions, mutilating scarring and premature mortality, com-
monly from squamous cell carcinomas (Fine et al., 2000;
Mallipeddi, 2002).
Genetic counseling based on Mendelian principles usually
advises that parents of affected offspring are asymptomatic
heterozygous carriers with a 25% risk of recurrence in
subsequent pregnancies, although a number of de novo
COL7A1 mutations have been reported (Uitto and Richard,
2004). Delineation of de novo mutations that are not present
in parental germline may substantially reduce, but not
completely abolish, the risk of recurrence. A further possibi-
lity, although not yet reported in RDEB, that has implications
for the accuracy of genetic counseling and risk of recurrence
is when molecular analysis discloses uniparental disomy
(UPD), a term used to denote the inheritance of both copies of
a chromosome pair from just one parent (paternal or maternal)
(Engel, 1980). Uniparental heterodisomy refers to the pre-
sence of a pair of chromosome homologs, whereas unipar-
ental isodisomy describes two identical copies of a single
homolog, and meroisodisomy is a mixture of the two (Kotzot,
2001; Siegel and Slavotinek, 2005). In essence, uniparental
isodisomy allows two copies of a recessive mutation to be
transmitted from a heterozygous carrier parent.
We report the first case of HS-RDEB due to UPD,
specifically complete maternal isodisomy, with reduction to
homozygosity of the mutant COL7A1 gene. Moreover, this is
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only the third reported example of UPD of chromosome 3
(Hoffman et al., 2004; Schollen et al., 2005).
RESULTS
The clinicopathological features of the blistering neonate
support a diagnosis of HS-RDEB
The proband was the first-born son of healthy unrelated
parents from Hong Kong. The mother was 34 years old and
the father was aged 35. There was no family history of
blistering skin diseases. The pregnancy, labor, and delivery
were uncomplicated and the proband was born at 39 weeks
gestation weighing 2,570 g (5th centile). At birth, there were
extensive erosions at acral sites and on his legs (Figure 1a and
b). He was otherwise clinically normal with no dysmorphic
features and cytogenetic analysis showed a normal 46XY
karyotype. Immunofluorescence microscopy demonstrated
type IV collagen immunostaining to the roof of a skin blister
(Figure 1c) and a complete absence of immunoreactivity for
type VII collagen (Figure 1d), but normal labeling intensities
for all other basement membrane components. These
investigations are consistent with a diagnosis of HS-RDEB.
Now aged 1 year, he continues to have fragile skin with
widespread trauma-induced blistering and erosions, more
prominent on his hands and face; however, with supportive
medical care he is thriving and is on the 50th centile for both
weight and height. Complete assessment of his psychomotor
development shows that he has achieved his appropriate
developmental milestones and no physical abnormalities,
other than the HS-RDEB, have been noted.
The molecular basis of the HS-RDEB is a new homozygous
frameshift mutation, 345insG, in exon 3 of COL7A1
Direct automated sequencing revealed that the affected child
was homozygous for a single-nucleotide insertion mutation,
345insG, in exon 3 of COL7A1 (Figure 2a), resulting in a
premature termination codon 36-bp downstream. This
mutation provides an explanation for the complete absence
of type VII collagen immunolabeling on the skin biopsy
(Figure 1d) and, although specific to this family, this mutation
is fully consistent with HS-RDEB. Examination of the
maternal DNA revealed that the mother was a heterozygous
carrier of this mutation (Figure 2b). The father’s DNA,
however, showed only wild-type sequence (Figure 2c). Thus,
the affected child was homozygous for the frameshift
mutation, 345insG, and at least one allele was inherited
from the mother.
Microsatellite analysis identifies complete maternal isodisomy
of chromosome 3 and excludes non-paternity
To establish the origin of the affected child’s second mutant
allele, haplotype analysis of the COL7A1 locus was initially
performed based on inheritance of seven highly heterozygous
microsatellite markers within 2 cM of the gene. These
microsatellites comprised: D3S3678, D3S1581, D3S3629,
D3S1568, D3S3026, D3S1578, and D3S1289 (see Table 1).
The results showed that the affected child was homozygous
for all seven markers, three of which (D3S3678, D3S1581,
and D3S1578) showed an absence of a paternally derived
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Figure 1. Clinical examination and skin immunohistochemistry indicate that
this child has Hallopeau–Siemens recessive dystrophic epidermolysis bullosa.
(a) Skin erosions and wound exudate/crust on the dorsum of the left hand and
fingers; (b) extensive skin loss and erosions on the lower legs and feet; (c) type
IV collagen immunostaining maps to the roof of a blister in the child’s skin
(blister cavity indicated by asterisk; bar¼50 mm); (d) there is a complete
absence of type VII collagen labeling in the child’s skin (blister cavity
indicated by asterisk; bar¼50 mm); and (e) in contrast, type VII collagen
immunolabeling in normal control skin shows bright linear fluorescence at
the dermal–epidermal junction (bar¼50 mm).
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Figure 2. Nucleotide sequencing reveals a homozygous frameshift in
COL7A1 in the affected child. Mother is a heterozygous carrier but father is
not. (a) Within exon 3 in the affected child’s DNA, there is a homozygous
single nucleotide insertion, 345insG (arrow): this frameshift results in a
premature termination codon 36-bp downstream; (b) sequencing of the
mother’s DNA reveals that she is a heterozygous carrier of 345insG; and (c) by
contrast, the father’s DNA shows wild-type exon 3 sequence only.
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chromosome 3, and one marker (D3S3678) was fully
informative for the child inheriting two copies of the mutated
maternal allele. To examine the inheritance of the mutated
alleles in the affected child further and to explore the
possibility of UPD in this family, extensive genotype analysis
of the entire chromosome 3 was performed using 21
additional microsatellite markers along the entire chromo-
some 3 (Table 1). The affected child was homozygous for all
21 of these markers, 10 of which were fully informative for
inheritance of two copies of a single maternal chromosome 3
in the affected child. For the non-chromosome 3 markers,
there were no discrepancies in the segregation of maternal
and paternal alleles to the affected child, thus excluding non-
paternity (data not shown). Normal karyotyping ruled out
monosomy of chromosome 3. The results in this family are
consistent with the inheritance of two identical copies of a
single chromosome 3 homolog from the mother, thus
indicating complete maternal isodisomy as the molecular
basis of the HS-RDEB in this family.
DISCUSSION
UPD (isodisomy or meroisodisomy) with homozygosity of
recessive alleles is being increasingly recognized as the
molecular basis for several autosomal recessive disorders
(Zlotogora, 2004). In fact, there have been over 35 reported
cases of recessive diseases resulting from UPD (Kotzot and
Utermann, 2005), although only two have involved chromo-
some 3. The first was a case of Fanconi Bickel syndrome
Table 1. Haplotype analysis using microsatellite markers spanning chromosome 3 is consistent with complete
maternal isodisomy
Locus Cytogenetic location Mother Affected child Father
D3S1297 3p26.3 358 358 358 358 352 362
D3S1304 3p26.1 258 268 268 268 258 268
D3S1263* 3p25.3 200 196 196 196 204 208
D3S2338* 3p24.3 90 102 102 102 104 104
D3S1277 3p23 297 295 295 295 293 295
D3S3678* 3p22.1 311 313 313 313 307 309
D3S1581 3p21.31 161 161 161 161 157 157
COL7A1 345insG 3p21.31 /+ +/+ /
D3S3629 3p21.31 339 337 337 337 337 337
D3S1568 3p21.31 337 335 335 335 335 343
D3S3026 3p21.2 224 224 224 224 224 224
D3S1578 3p21.1 200 200 200 200 188 196
D3S1289 3p21.1–p14.3 245 241 241 241 241 247
D3S1300* 3p14.2 254 250 250 250 235 235
D3S1285 3p14.1 245 241 241 241 241 243
D3S1566* 3p13 167 173 173 173 167 175
D3S3681* 3p12.3–p12.2 138 154 154 154 146 150
D3S1271 3q12.2 92 88 88 88 88 88
D3S1278 3q13.31 231 231 231 231 231 231
D3S1267* 3q21.1 120 116 116 116 96 96
D3S1292* 3q22.1 128 131 131 131 120 143
D3S1569* 3q24 170 162 162 162 164 178
D3S1279* 3q25.1 270 266 266 266 272 272
D3S1614 3q26.2 108 108 108 108 108 118
D3S1565 3q26.31 180 180 180 180 186 186
D3S1262* 3q27.3 130 122 122 122 112 124
D3S1580 3q28 231 231 231 231 226 234
D3S1601 3q28 306 306 306 306 306 320
D3S1311 3q29 135 135 135 135 145 151
The data show that the affected child has inherited two copies of a single maternal chromosome 3 (highlighted in bold). Marker order and cytogenetic
location are derived from USCS Genome Bioinformatics (http://genome.ucsc.edu/); fully informative markers are indicated by asterisks (*).
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(OMIM 227810) caused by maternal isodisomy of chromo-
some 3 and reduction to homozygosity of a mutation in the
glucose transporter gene GLUT2 (Hoffman et al., 2004). The
second was a patient with a congenital disorder of
glycosylation type Id (OMIM 601110) caused by a homo-
zygous mutation in a mannosyl transferase gene, ALG3,
resulting from a de novo mutation in combination with
segmental maternal isodisomy (Schollen et al., 2005). Our
case of HS-RDEB represents the third case of UPD of
chromosome 3 and the second case of complete maternal
isodisomy for this chromosome. However, this is not the first
case of epidermolysis bullosa to result from UPD. Indeed,
there have been four reported cases, all involving chromo-
some 1 in patients with Herlitz junctional epidermolysis
bullosa (OMIM 226700). Three of these cases resulted from
reduction to homozygosity of a mutation in the LAMB3 gene
(locus 1q32.2) (Pulkkinen et al., 1997; Takizawa et al., 1998;
Fassihi et al., 2005) and one involved a mutation in LAMC2
(1q25.3) (Takizawa et al., 2000).
For certain chromosomes, UPD can also result in distinct
phenotypes depending on the parental origin of the chromo-
somes, a phenomenon known as genomic imprinting. This
parent-of-origin specific gene expression is determined by
epigenetic modification of a specific gene or, more often, a
group of genes, such that gene transcription is altered and
only one inherited copy of the relevant imprinted gene(s) is
expressed in the embryo. (Swales and Spears, 2005). This
means that during development, the parental genomes
function unequally in the offspring, the most common
examples of genomic imprinting being Prader–Willi (OMIM
176270) and Angelman (OMIM 105830) syndromes, which
can result from maternal or paternal UPD for chromosome
15, respectively (Nicholls and Knepper, 2001). Three
phenotype abnormalities commonly associated with UPD
for chromosomes with imprinting are intrauterine growth
retardation, developmental delay, and reduced stature
(Miozzo and Simoni, 2002; Coan et al., 2005). For the
chromosome 3 UPD in our case of HS-RDEB, the child did
have a low birth weight; however, it is plausible that any
intrauterine growth restriction could simply have been due to
the blistering skin disease (Fox et al., 2003). Moreover,
physical examination over the first year of this child’s life has
not shown any significant growth or developmental abnor-
malities, observations that suggest an absence of clinically
significant maternally imprinted genes on chromosome 3,
although clearly further clinical follow-up will be necessary
to confirm this initial impression. Indeed, thus far there have
been no reports of imprinted genes on human chromosome 3
(Morison et al., 2005).
The mechanisms underlying UPD are diverse and include
gamete complementation (non-disjunction in meiosis leading
to a diploid gamete with two copies of a chromosome
fertilized by a nullosomic gamete lacking the same chromo-
some), trisomy rescue (chromosome loss in trisomy), monos-
omy rescue (chromosome duplication in monosomy), and
postfertilization error (Robinson, 2000). In monosomy rescue,
non-disjunction in meiotic division II in one parent results in
disomic and nullisomic gametes. Subsequent to fertilization
of the nullisomic gamete with a haploid gamete, the entire
chromosome is duplicated, yielding two identical copies of
this chromosome. Monosomy rescue must occur early after
fertilization as most monosomies are lethal, resulting in
miscarriage early in pregnancy. In our patient, fertilization of
a nullisomic sperm by a normal egg with subsequent salvage
of a monosomy by postfertilization duplication of the
maternal chromosome 3 is the most likely cause of UPD
and homozygosity for the COL7A1 locus containing the
mutation 345insG (Kotzot and Utermann, 2005). However,
loss of paternally derived chromosome 3 from a trisomic
zygote (trisomy rescue) or fertilization between a disomic egg
(non-disjunction at meiosis II) and a nullisomic sperm
(gamete complementation) with no preceding recombination
at meiosis I might also be possible.
UPD is a rare but important cause of autosomal recessive
disorders, with significant implications for both mutation
screening and genetic counseling. In screening for mutations
in HS-RDEB, or indeed any autosomal recessive condition,
DNA samples should be obtained from both parents as well
as the proband so that transmission of the mutated allele(s)
can be fully determined. Parents, in whom UPD has
occurred, can be counseled that the possibility of recurrence
of HS-RDEB is much lower than the usual 25% risk in parents
who are both heterozygous carriers of this autosomal
recessive disorder. Indeed, thus far there have been no
reports of recurrence of any genetic disease in such couples.
In summary, this is the first case of UPD to be described in
HS-RDEB and is only the third example of UPD of
chromosome 3 to be reported. The lack of an observable
phenotype during the first year of life other than the HS-RDEB
in this case of maternal isodisomy suggests that maternally
derived genes on human chromosome 3 are not imprinted.
MATERIALS AND METHODS
Immunofluorescence microscopy
Following ethical approval, informed consent and in compliance
with the Declaration of Helsinki Principles, a skin biopsy was taken
under local anesthesia from clinically uninvolved skin on the
buttock. Indirect immunofluorescence staining was performed on
5mm cryosections of skin with the monoclonal antibodies LH7:2
(NC-1 domain of type VII collagen, a gift from Dr I.M. Leigh) (Leigh
et al., 1988), GB3 (conformational epitope on g2 chain of laminin 5,
Oxford Biotechnology Ltd (Kidlington, UK) (Verrando et al., 1991)
and COL94 (type IV collagen, Sigma, Poole, UK). The antibodies
were diluted 1:1,000, 1:300, and 1:500, respectively, in phosphate-
buffered saline/bovine serum albumin. Labeling procedures were as
described previously (Kennedy et al., 1985). Fluorescein isothiocya-
nate-labeled anti-mouse and anti-rabbit secondary antibodies (Dako,
Glostrup, Denmark) were used diluted 1:200 in phosphate-buffered
saline/bovine serum albumin.
Mutation analysis
DNA was extracted from peripheral blood samples taken from the
proband and his parents using standard protocols. Mutation
detection strategy consisted of heteroduplex scanning by conforma-
tion-sensitive gel electrophoresis of all 118 exons of COL7A1.
Laboratory protocols and details of the specific primers have been
2042 Journal of Investigative Dermatology (2006), Volume 126
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described elsewhere (Christiano et al., 1997b). The corresponding
PCR products showing heteroduplexes were subjected to
bi-directional automated nucleotide sequencing using an ABI Prism
310 Genetic Analyzer.
Genotype analysis
For haplotype analysis of the COL7A1 locus, seven highly
heterozygous microsatellite markers within 2 cM of the gene were
initially tested (D1S3678, D3S1581, D3S3629, D3S1568, D3S3026,
D3S1578, and D1S1289). In addition, 21 further microsatellite
markers spanning the entire chromosome 3, approximately 10 cM
apart, were analysed from the proband and his parents. Non-
paternity was investigated using six non-chromosome 3 markers
(D1S425, D1S2703, D1S205, D1S491, D6S291, and D6S276). All
microsatellite markers were from the ABI Prism Linkage Mapping Set
Version 2.5 (Applied Biosystems, Warrington, UK), were amplified
with fluorescently labeled oligonucleotides, and used under condi-
tions recommended by the manufacturer. Electrophoretic analysis
was performed on an ABI Prism 310 Genetic Analyzer with
Performance Optimized Polymer 4 (POP4) using Genescan software
(Applied Biosystems). The allele sizes were analysed using Genoty-
per software (Applied Biosystems).
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